Challenges of AI for cost-effectiveness in health: a hybrid MCDM model
- 1School of Health Sciences, Deparment of Health Management, Istanbul Medipol University
Abstract
Objective This study aims to elucidate the role of artificial intelligence (AI) in achieving cost-effectiveness within healthcare services, and to address the challenges that hinder its integration. Methods A hybrid multi-criteria decision-making model based on the DEMATEL and ARAS methods was designed. Data were collected with the participation of ten experts working in the fields of health management, health economics and health policy in Canada, India, Switzerland, USA and Türkiye. The causal relationships between the challenges were analyzed using DEMATEL analysis and the solutions to these challenges were evaluated using the ARAS method. Results As a result of the DEMATEL analysis, the “Regulatory and ethical concerns (REC)” criterion reached the highest level of importance (13.94%), followed by “High initial costs and financial constraints (ICFC)” (13.65%) and “Lack of data standardization and biases (DBHQ)” (13.29%). In the ARAS evaluation, among the proposed solutions, “Carrying out comprehensive awareness-raising activities for patients and their relatives (SS3)” achieved the highest performance value (Ki = 0.93), followed by “Providing inclusive incentives for AI transformation (SS5)” (Ki = 0.87) and “Establishing a blockchain-based cybersecurity system (SS2)” (Ki = 0.85). Conclusions To achieve cost-effectiveness through AI in healthcare, it is imperative to establish a robust, integrated, and standardized data infrastructure, develop comprehensive ethical and regulatory frameworks, and implement patient education programs to foster trust and acceptance of AI technologies. This study provides policymakers and practitioners with evidence-based recommendations to facilitate the successful integration of AI in healthcare, ultimately enhancing cost-efficiency and service delivery.
Related
- Effectiveness, cost-effectiveness and implementation of WHO psychological interventions for migrant populations resettled in Italy: study protocol for the ADVANCE hybrid type-I randomized controlled trial
- Cost‐effectiveness analysis comparing advanced hybrid closed‐loop automated insulin delivery with multiple daily insulin injections and continuous glucose monitoring in adults with type 1 diabetes in Japan
- The MCH-HB Adjara Study: protocol for a non-randomised hybrid type 1 effectiveness–implementation study of the Maternal and Child Health Handbook in Georgia
- Implementing a digitally enabled wound model of care to improve chronic wound outcomes in seven health services in Australia: study protocol for a multisite, hybrid type 2, two-phase effectiveness-implementation trial (the ENABLE study)
- Cost-effectiveness of an integrated lifestyle intervention for obesity in southern Italy: a model-based simulation of costs, health outcomes and gastrointestinal cancer burden
BibTeX
@article{uslu2026challenges,
title = {{Challenges of AI for cost-effectiveness in health: a hybrid MCDM model}},
author = {Yeter Uslu and Erman Gedikli and Emre Yılmaz},
journal = {Health Economics Review},
year = {2026},
month = jul,
doi = {10.1186/s13561-026-00821-0},
url = {https://doi.org/10.1186/s13561-026-00821-0},
note = {CC BY},
}
RIS
TY - JOUR
TI - Challenges of AI for cost-effectiveness in health: a hybrid MCDM model
AU - Yeter Uslu
AU - Erman Gedikli
AU - Emre Yılmaz
PY - 2026
DA - 2026/07/01
JO - Health Economics Review
DO - 10.1186/s13561-026-00821-0
UR - https://doi.org/10.1186/s13561-026-00821-0
AB - Objective This study aims to elucidate the role of artificial intelligence (AI) in achieving cost-effectiveness within healthcare services, and to address the challenges that hinder its integration. Methods A hybrid multi-criteria decision-making model based on the DEMATEL and ARAS methods was designed. Data were collected with the participation of ten experts working in the fields of health management, health economics and health policy in Canada, India, Switzerland, USA and Türkiye. The causal relationships between the challenges were analyzed using DEMATEL analysis and the solutions to these challenges were evaluated using the ARAS method. Results As a result of the DEMATEL analysis, the “Regulatory and ethical concerns (REC)” criterion reached the highest level of importance (13.94%), followed by “High initial costs and financial constraints (ICFC)” (13.65%) and “Lack of data standardization and biases (DBHQ)” (13.29%). In the ARAS evaluation, among the proposed solutions, “Carrying out comprehensive awareness-raising activities for patients and their relatives (SS3)” achieved the highest performance value (Ki = 0.93), followed by “Providing inclusive incentives for AI transformation (SS5)” (Ki = 0.87) and “Establishing a blockchain-based cybersecurity system (SS2)” (Ki = 0.85). Conclusions To achieve cost-effectiveness through AI in healthcare, it is imperative to establish a robust, integrated, and standardized data infrastructure, develop comprehensive ethical and regulatory frameworks, and implement patient education programs to foster trust and acceptance of AI technologies. This study provides policymakers and practitioners with evidence-based recommendations to facilitate the successful integration of AI in healthcare, ultimately enhancing cost-efficiency and service delivery.
SN - 2191-1991
ER -